VYNE Therapeutics Inc. (VYNE)
undefined
undefined%
At close: undefined
2.56
0.39%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -28.45M -23.21M -73.33M -255.57M -73.70M -51.45M -29.08M -14.07M -4.61M
Depreciation & Amortization - 72.00K 109.00K 341.00K 700.00K 22.00K 8.00K 4.00K -
Stock-Based Compensation 3.31M 4.30M 8.08M 18.10M 6.70M 3.64M 1.45M 573.00K 65.00K
Other Working Capital 214.00K -349.00K -371.00K -4.17M 1.41M -8.55M -1.74M 10.18M 360.00K
Other Non-Cash Items -254.00K -12.64M 2.47M 84.07M -691.00K -774.00K 31.00K 705.00K 65.00K
Deferred Income Tax - - 1.52M 56.30M - - 60.00K -573.00K -
Change in Working Capital 60.00K 2.28M 4.78M -40.33M 1.89M -4.17M -722.00K 11.07M 360.00K
Operating Cash Flow -25.34M -29.20M -56.37M -137.08M -65.10M -52.73M -28.25M -2.29M -4.18M
Capital Expenditures - - - -113.00K -11.00K -140.00K -27.00K -31.00K -
Acquisitions 5.00M 15.67M - 38.64M 40.00K - -25.00K - -
Purchase of Investments -62.35M - - -38.64M -83.40M -126.70M -64.15M -55.31M -
Sales Maturities Of Investments - - 1.03M 50.58M 124.78M 92.96M 49.11M 17.85M -
Other Investing Acitivies - 15.67M - 38.64M -40.00K - 25.00K - -
Investing Cash Flow -57.35M 15.67M 1.03M 89.11M 41.37M -33.88M -15.06M -37.49M -
Debt Repayment - - -36.43M - - - - - -
Common Stock Repurchased -360.00K - - - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies -427.00K 183.00K 228.00K 169.00K 465.00K 496.00K 49.49M - 47.72M
Financial Cash Flow 82.39M 1.65M 39.78M 61.81M 4.99M 125.91M 49.49M - 47.72M
Net Cash Flow -301.00K -11.88M -15.56M 13.83M -18.73M 39.30M 6.18M -39.78M 43.53M
Free Cash Flow -25.34M -29.20M -56.37M -137.19M -65.11M -52.87M -28.27M -2.32M -4.18M